Diabetes mellitus und Demenz: neue Daten

Literatur
1 Allen VJ, Methven L, Gosney MA. Use of nutritional complete supplements in older adults with dementia: systematic review and meta-analysis of clinical outcomes. Clin Nutr 2013; Mar 28 [Epub ahead of print]
2 Buchman AS, Boyle PA, Yu L et al. Total daily physical activity and the risk of AD and cognitive decline in older adults. Neurology 2012; 78: 1323-1329
3 Bomfim TR, Forny-Germano L, Sathler LB et al. An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease-associated Aβ oligomers. J Clin Invest 2012; 122: 1339-1353
4 Craft S, Baker LD, Montine TJ et al. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Arch Neurol 2012; 69: 29-38
5 Crane PK, Walker R, Hubbard RA et al. Glucose levels and risk of dementia. N Engl J Med 2013; 369: 540-548
6 Feinkohl I, Aung PP, Keller M et al. Edinburgh Type 2 Diabetes Study (ET2DS) Investigators. Severe hypoglycemia and cognitive decline in older people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes Care 2013; Oct 8. [Epub ahead of print]
7 Fitzpatrick AL, Kuller LH, Lopez OL et al. Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Arch Neurol 2009; 66: 336-342
8 Kopf D, Frölich L. Risk of incident Alzheimer's disease in diabetic patients: a systematic review of prospective trials. J Alzheimers Dis 2009; 16: 677-685
9 Launer LJ, Miller ME, Williamson JD et al. ACCORD MIND investigators. Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy. Lancet Neurol 2011; 10: 969-977
10 Pandini G, Pace V, Copani A et al. Insulin has multiple antiamyloidogenic effects on human neuronal cells. Endocrinology 2013; 154: 375-387
11 Ravona-Springer R, Schnaider-Beeri M, Goldbourt U. Body weight variability in midlife and risk for dementia in old age. Neurology 2013; 80: 1677-1683
12 Scheltens P, Twisk JW, Blesa R et al. Efficacy of Souvenaid in mild Alzheimer's disease: results from a randomized, controlled trial. J Alzheimers Dis 2012; 31: 225-236
13 Stange I, Bartram M, Liao Y et al. Effects of a low-volume, nutrient- and energy-dense oral nutritional supplement on nutritional and functional status: a randomized, controlled trial in nursing home residents. J Am Med Dir Assoc 2013; 14: 628.e1-8
14 Sullivan MD, Katon WJ, Lovato LC et al. Association of depression with accelerated cognitive decline among patients with type 2 diabetes in the ACCORD-MIND Trial. JAMA Psychiat 2013; 70 (10) 1041-1047
15 Thambisetty M, Metter EJ, Yang A et al. Glucose intolerance, insulin resistance, and pathological features of Alzheimer disease in the Baltimore Longitudinal Study of Aging. JAMA Neurol 2013; 70 (09) 1167-1172